Editor's Corner
![]()
We've got a great lineup of speakers for FierceBiotech's upcoming webinar on venture capital in 2006. Steven Burrill of Burrill & Co., Sherrill Neff of Quaker BioVentures and Scott Minick of Arch Venture Partners will all be on hand October 27 at 2pm ET to discuss what they see as the most important trends influencing the biotech companies raising funds in the year ahead. Gil Forer of Ernst & Young will lead things off with a discussion of the key trends we've seen so far this year and how they'll likely develop in months to come. Next week we'll start running promos on the webinar where you can sign up. If you have any plans to raise funds or will be advising biotech executives on what they need to do to better position themselves, this will be the best hour-long commitment you ever made. Next year FierceBiotech plans to put on a series of webinars as we broaden our coverage of the industry. If you have any ideas, email them to me. Your feedback is valuable. - John Carroll
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


